Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (461-470 of 625) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|July 12, 2025
Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarkers in giant cell arteritisRexhep Durmo, Francesco Muratore, Chiara Marvisi, et al.
Scientific Reports|March 10, 2017
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
Case Reports in Neurology|July 21, 2023
Intracranial Stenosis Treated with Stenting in Patients with Suspected Cerebral Vasculitis: Two Case ReportsGabriele Vandelli, Laura Giacobazzi, Ludovico Ciolli, et al.
Scientific Reports|April 6, 2017
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. EfficacyRoberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
Critical Care (London, England)|September 30, 2020
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilationFrancesco Menzella, Matteo Fontana, Carlo Salvarani, et al.
Clinical and Experimental Rheumatology|November 6, 2025
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseasesStiliano Maimaris, Giuseppe Germanò, Arianna Torre, et al.
Rheumatology (Oxford, England)|April 8, 2021
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA studyVerena Schönau, Jessica Roth, Koray Tascilar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2020
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern ItalyCarlo Salvarani, Pamela Mancuso, Federica Gradellini, et al.
Annals of the Rheumatic Diseases|June 28, 2018
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 studyDominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, et al.
Pageof 63

Showing results (461-470 of 625) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|July 12, 2025
Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarkers in giant cell arteritisRexhep Durmo, Francesco Muratore, Chiara Marvisi, et al.
Scientific Reports|March 10, 2017
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
Case Reports in Neurology|July 21, 2023
Intracranial Stenosis Treated with Stenting in Patients with Suspected Cerebral Vasculitis: Two Case ReportsGabriele Vandelli, Laura Giacobazzi, Ludovico Ciolli, et al.
Scientific Reports|April 6, 2017
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategyF David Carmona, Patrick Coit, Güher Saruhan-Direskeneli, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. EfficacyRoberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
Critical Care (London, England)|September 30, 2020
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilationFrancesco Menzella, Matteo Fontana, Carlo Salvarani, et al.
Clinical and Experimental Rheumatology|November 6, 2025
The high prevalence of Whipple's disease in patients with inflammatory rheumatic diseasesStiliano Maimaris, Giuseppe Germanò, Arianna Torre, et al.
Rheumatology (Oxford, England)|April 8, 2021
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA studyVerena Schönau, Jessica Roth, Koray Tascilar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 9, 2020
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern ItalyCarlo Salvarani, Pamela Mancuso, Federica Gradellini, et al.
Annals of the Rheumatic Diseases|June 28, 2018
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 studyDominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, et al.
Pageof 63